ACRO BIOMEDICAL CO., LTD. (ACBM) Operating income 2017–2025
ACRO BIOMEDICAL CO., LTD. (ACBM) annual operating income history from SEC filings — each fiscal year as reported.
-$154,024FY2025 · since FY2017: -$2,248 → -$154,024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$154,024 | -305.8% |
| FY2024 | -$37,958 | +99.6% |
| FY2023 | -$8.8M | +44.5% |
| FY2022 | -$15.9M | -106.3% |
| FY2021 | -$7.7M | -5797.1% |
| FY2020 | -$130,463 | +69.1% |
| FY2019 | -$422,751 | -182.0% |
| FY2018 | $515,550 | +23033.7% |
| FY2017 | -$2,248 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACBM financial trends
ACBM RevenueACBM Net incomeACBM Net marginACBM Gross profitACBM Gross marginACBM Operating marginACBM Operating cash flowACBM Free cash flowACBM Capital expendituresACBM Return on equityACBM Stock buybacksACBM Dividends paidACBM Total assetsACBM Total liabilitiesACBM Shareholders’ equityACBM overview →